Using specialized nanoparticles, MIT engineers have developed a way to monitor pneumonia or other lung diseases by analyzing the breath exhaled by the patient. In a study of mice, the researchers showed that they could use this system to monitor bacterial pneumonia and a genetic disorder of the lungs called alpha-1 antitrypsin deficiency.
An official website of the United States government.